Gene · 5710
Papers1,432
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,432
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| High-throughput assay exploiting disorder-to-order conformational switches: application to the proteasomal Rpn10:E6AP complex. | Chem Sci | 2024 | 38487241 | PubTator, text mining | PubMed |
| Molecular basis of SAP05-mediated ubiquitin-independent proteasomal degradation of transcription factors. | Nat Commun | 2024 | 38326322 | PubTator, text mining | PubMed |
| RcMYB8 enhances salt and drought tolerance in rose (Rosa chinensis) by modulating RcPR5/1 and RcP5CS1. | Mol Hortic | 2024 | 38282004 | PubTator, text mining | PubMed |
| Multi-omics and pathway analyses of genome-wide associations implicate regulation and immunity in verbal declarative memory performance. | Alzheimers Res Ther | 2024 | 38245754 | PubTator, text mining | PubMed |
| Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. | Blood Cancer J | 2024 | 38199987 | PubTator, text mining | PubMed |
| Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. | Commun Med (Lond) | 2024 | 38172536 | PubTator, text mining | PubMed |
| Proteotoxic stress and the ubiquitin proteasome system. | Semin Cell Dev Biol | 2024 | 37734998 | PubTator, text mining | PubMed |
| Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma. | Haematologica | 2024 | 37608776 | PubTator, text mining | PubMed |
| Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma. | CNS Neurosci Ther | 2024 | 37485655 | PubTator, text mining | PubMed |
| Colorectal Cancer Immunotherapy: State of the Art and Future Directions. | Gastro Hep Adv | 2023 | 38098742 | PubTator, text mining | PubMed |
| Recessive SERPING1 Variant Leads to Kinin-Kallikrein System Control Failure in a Consanguineous Brazilian Family with Hereditary Angioedema. | J Clin Med | 2023 | 38068351 | PubTator, text mining | PubMed |
| Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. | Cancers (Basel) | 2023 | 38067336 | PubTator, text mining | PubMed |
| Bimodular architecture of bacterial effector SAP05 that drives ubiquitin-independent targeted protein degradation. | Proc Natl Acad Sci U S A | 2023 | 38039272 | PubTator, text mining | PubMed |
| Lipid-anchored proteasomes control membrane protein homeostasis. | Sci Adv | 2023 | 38019907 | PubTator, text mining | PubMed |
| Purification and characterization of different proteasome species from mammalian cells. | STAR Protoc | 2023 | 37999974 | PubTator, text mining | PubMed |
| Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs. | Microbiol Spectr | 2023 | 37943512 | PubTator, text mining | PubMed |
| S-Nitrosylated Proteins Involved in Autophagy in Triticum aestivum Roots: A Bottom-Up Proteomics Approach and In Silico Predictive Algorithms. | Life (Basel) | 2023 | 37895406 | PubTator, text mining | PubMed |
| Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer. | Oncogene | 2023 | 37864031 | PubTator, text mining | PubMed |
| An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. | Front Pharmacol | 2023 | 37860119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5710/papers?page=3